Skip to main content

Pfizer Inc (PFE) Stock

Pfizer Inc Stock Details, Movements and Public Alerts

Stock Details

Pfizer Inc (PFE), a prominent company in the healthcare sector within the drug manufacturers - general industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $26.08. Over the past 52 weeks, it has ranged between $19.50 and $26.83. This places the current price at 97.2% of its 52-week high and 33.7% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 61.30, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $25.08 by 3.99%. Similarly, it is above its 200-day moving average of $23.73 by 9.90%. The MACD histogram is 0.11, indicating bullish momentum (MACD Line: 0.32, Signal Line: 0.21). The International Securities Identification Number (ISIN) for this stock is US7170811035. There are currently 6 active alerts set for PFE by users.

52-Week Range

$26.83 - $19.50

-2.80% from high · +33.74% from low

Avg Daily Volume

48,153,334

20-day average

100-day avg: 60,902,044

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

15.03

Near market average

Forward P/E

9.14

Earnings expected to grow

PEG Ratio

3.77

Potentially overvalued

Price to Book

1.62

EV/EBITDA

10.60

EPS (TTM)

$1.72

Price to Sales

2.34

Beta

0.43

Less volatile than market

Q:How is PFE valued relative to its earnings and growth?
Pfizer Inc trades at a P/E ratio of 15.03, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 9.14 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 3.77 indicates a premium valuation even accounting for growth.
Q:What is PFE's risk profile compared to the market?
With a beta of 0.43, Pfizer Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 1.62 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

15.70%

Operating Margin

35.30%

EBITDA

$24.46B

Return on Equity

10.60%

Return on Assets

5.19%

Revenue Growth (YoY)

-5.90%

Earnings Growth (YoY)

-21.30%

Q:How profitable and efficient is PFE's business model?
Pfizer Inc achieves a profit margin of 15.70%, meaning it retains $15.70 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of 35.30% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 10.60% and ROA at 5.19%, the company achieves moderate returns on invested capital.
Q:What are PFE's recent growth trends?
Pfizer Inc's revenue declined by 5.90% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. Earnings decreased by 21.30% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against DRUG MANUFACTURERS - GENERAL industry averages for proper context.

Dividend Information

Dividend Per Share

$1.70

Dividend Yield

6.42%

Ex-Dividend Date

Jan 23, 2026

Dividend Date

Mar 6, 2026

Q:What dividend income can investors expect from PFE?
Pfizer Inc offers a dividend yield of 6.42%, paying $1.70 per share annually. This high yield exceeds 4%, significantly outperforming the S&P 500 average of 1.5-2% and most investment-grade bonds. For income-focused investors, this represents an attractive cash flow opportunity, though high yields sometimes signal market concerns about sustainability. To receive the next dividend, shares must be purchased before the ex-dividend date of Jan 23, 2026.
Q:How reliable is PFE's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - Pfizer Inc pays $1.70 per share in dividends against earnings of $1.72 per share, resulting in a payout ratio of 98.84%. This very high payout exceeding 90% raises sustainability concerns, as nearly all earnings go to dividends. Any earnings decline could force a dividend cut. The next dividend payment is scheduled for Mar 6, 2026.

Company Size & Market

Market Cap

$147.0B

Revenue (TTM)

$62.78B

Revenue/Share (TTM)

$11.06

Shares Outstanding

5.69B

Book Value/Share

$16.32

Asset Type

Common Stock

Q:What is PFE's market capitalization and position?
Pfizer Inc has a market capitalization of $147.0B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 5.69B shares outstanding, the company's ownership is widely distributed. As a major player in the DRUG MANUFACTURERS - GENERAL industry, it competes with other firms in this sector.
Q:How does PFE's price compare to its book value?
Pfizer Inc's book value per share is $16.32, while the current stock price is $26.08, resulting in a price-to-book (P/B) ratio of 1.60. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$28.78

10.35% upside potential

Analyst Recommendations

Strong Buy

3

Buy

7

Hold

15

Sell

1

Strong Sell

0

Q:How reliable are analyst predictions for PFE?
26 analysts cover PFE with 38% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $28.78 implies 10.4% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on PFE?
Current analyst recommendations:3 Strong Buy, 7 Buy, 15 Hold, 1 Sell, 0The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jan 30, 2026, 02:08 AM

Technical Indicators

RSI (14-day)

61.30

Neutral

50-Day Moving Average

$25.08

3.99% above MA-50

200-Day Moving Average

$23.73

9.90% above MA-200

MACD Line

0.32

MACD Signal

0.21

MACD Histogram

0.11

Bullish

Q:What does PFE's RSI value tell investors?
The RSI (Relative Strength Index) for PFE is currently 61.30, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret PFE's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.32 above the signal line at 0.21, with histogram at 0.11. This bullish crossover suggests upward momentum is building. The 50-day MA ($25.08) is above the 200-day MA ($23.73), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Jan 30, 2026, 12:33 AM

Active Alerts

Alert Condition
Forward P/E falls below
Threshold
7.37 x
Created
Jan 21, 2026, 05:21 PM
Alert Condition
MA Breakout (Bearish)
Threshold
50 days
Created
Jan 20, 2026, 05:18 PM
Alert Condition
Earnings Announcement
Threshold
3 days
Created
Jan 12, 2026, 04:31 PM
Alert Condition
Price rises above
Threshold
$27.00
Created
Jan 4, 2026, 07:02 PM
Alert Condition
Price rises above
Threshold
$27.50
Created
Nov 13, 2025, 03:24 PM
Alert Condition
Price rises above
Threshold
$29.00
Created
Sep 6, 2025, 08:46 AM

Stay Ahead of the Market with Pfizer Inc Alerts

Set up price alerts for Pfizer Inc and get notified instantly when the price hits your target. Never miss an important price movement again.